Chirale Arzneimittel. Scale-up, Kontrolle und deren Bedeutung für die pharmazeutische Forschung
- 1 April 1993
- journal article
- research article
- Published by Wiley in Chemie in Unserer Zeit
- Vol. 27 (2) , 78-87
- https://doi.org/10.1002/ciuz.19930270205
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- CHIRAL DRUGSChemical & Engineering News, 1992
- Thalidomide enantiomersThe Lancet, 1992
- The relevance of chirality to the study of biological activityTetrahedron, 1992
- Talc products agency in UKAdditives for Polymers, 1991
- Racemic mixtures and single stereoisomers: Industrial concerns and issues in drug developmentChirality, 1991
- Synthesis of optically active compounds: A large scale perspectiveTetrahedron, 1991
- Regulatory aspects of the development of chiral drugs in Japan: A status reportChirality, 1991
- Asymmetric synthesis and teratogenic activity of (R)- and (S)-2-ethylhexanoic acid, a metabolite of the plasticizer di-(2-ethylhexyl)phthalateLife Sciences, 1990
- The FDA perspective on the development of stereoisomersChirality, 1989
- Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacologyEuropean Journal of Clinical Pharmacology, 1984